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Abstract
A rapid and reproducible stability indicating TLC method was developed for the determination of prednisolone
acetate and chloramphenicol in presence of their degraded products. Uniform degradation conditions were
maintained by refluxing sixteen reaction mixtures for two hours at 80°C using parallel synthesizer including acidic,
alkaline and neutral hydrolysis, oxidation and wet heating degradation. Oxidation at room temperature,
photochemical and dry heating degradation studies were also carried out. Separation was done on TLC glass
plates, pre-coated with silica gel 60F-254 using chloroform: methanol (14:1 v/v). Spots at Rf 0.21 ± 0.02 and Rf 0.41
± 0.03 were recognized as chloramphenicol and prednisolone acetate, respectively. Quantitative analysis was done
through densitometric measurements at multiwavelength (243 nm, lmax of prednisolone acetate and 278 nm, lmax
of chloramphenicol), simultaneously. The developed method was optimized and validated as per ICH guidelines.
Method was found linear over the concentration range of 200-6000 ng/spot with the correlation coefficient (r2 ± S.
D.) of 0.9976 ± 3.5 and 0.9920 ± 2.5 for prednisolone acetate and chloramphenicol, respectively. The developed
TLC method can be applied for routine analysis of prednisolone acetate and chloramphenicol in presence of their
degraded products in their individual and combined pharmaceutical formulations.
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Introduction
Prednisolone acetate (1), is a corticosteroid, used in
polychemotherapy of cancer and also as an immunosup-
pressive to treat allergic disorders and hypersensitivity
reactions [1,2]. Chloramphenicol (2), an antibiotic, pos-
sesses broad spectrum antibacterial activity and is used
for the treatment of rickettsial and chlamydial diseases,
gram + ve and gram -ve bacterial infections and topi-
cally for superficial conjunctivial infections [3]. A num-
ber of corticosteroid and antibiotic combinations are
frequently used as antibacterial agents to cure infections
particularly associated with the eye. These combinations
are available in different formulations including eye
ointment, eye drops and ophthalmic suspensions.
Ophthalmic preparations of prednisolone acetate along
with chloramphenicol are widely practiced for the treat-
ment of superficial eye infections. However, this combi-
nation is not official with British Pharmacopoeia or US
Pharmacopoeia. Many analytical methods have been
reported for the determination of prednisolone acetate
in cosmetics, Chinese medicinal preparations, human
serum, urine and pharmaceutical preparations [4-6].
HPLC and UPLC methods are also reported for the esti-
mation of chloramphenicol in aquatic products, pharma-
ceutical preparations, cosmetics comedo cream, blood,
gastric contents, urine, tissues and cerebrospinal fluid
[7-11].
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Simultaneous determination of prednisolone, chloram-
phenicol and a degraded product, 2- amino-1-(4-nitro-
phenyl)propane-1,3-diol in ophthalmic solutions
through HPLC is also reported [12]. Few HPTLC meth-
ods have also been reported for the determination of
chloramphenicol in combination with benzocaine and 2-
amino-1-(4-nitrophenyl) propane-1,3-diol (ANPD), and
for different corticosteroids including hydrocortisone,
hydrocortisone acetate, prednisolone, betamethasone-17-
valerate, prednisolone sodium phosphate, dexametha-
sone sodium phosphate and betamethasone sodium
phosphate [13]. No report for the simultaneous determi-
nation of prednisolone acetate and chloramphenicol in
the presence of their degraded products through TLC-
densitometry has been found so far.
Intensive consideration and attention is being paid to
the development of TLC-densitometry stability-indicat-
ing assay as it is fast, reliable and accurate and involves
simultaneous analysis of many samples by using small
quantity of mobile phase, thus minimizing analysis time
and cost per analysis. Stress testing provides evidence
that how the quality of a drug substance varies with
time under the influence of various environmental fac-
tors (temperature, light, humidity, etc.) and helps to
establish shelf life and recommended storage conditions
for the drug [14].
Taking ICH guidelines Q1A in consideration, present
study describes a simple and a validated TLC-densito-
metry method [15] for the simultaneous determination
of prednisolone acetate and chloramphenicol in pre-
sence of their degraded products formed under the
applied stress conditions. As all the pharmaceutical pro-
ducts are supposed to be assayed for potency, a vali-
dated TLC-densitometry method, demonstrating no
interferences of degraded products with the drug active
components can be useful in measuring these compo-
nents in routine analysis.
Experimental
Standards, prednisolone acetate (1) and chloramphenicol
(2), (Figure 1), were complementarily provided by Santa
(Pvt.) Ltd, Karachi, Pakistan. Pharmaceutical products
including prednisolone acetate eye drops (P1, Ophtha
Pred, Schazoo; P2, Mildo Pred, Remington; P3, Pre-
dforte, Barrette Hodgson; P4, Pred +, Schazoo; P5,
Prens, Vega), chloramphenicol eye drops (C1, spersini-
col, Novartis; C2, chloroptic, Barrette Hodgson) and
capsule (C3, chlormycetin, Pfizer), and ophthalmic sus-
pensions containing prednisolone acetate and chloram-
phenicol in combination (PC1, prednisynth, Schazoo;
PC2, prednicol, Remington) along with two expired
pharmaceutical products (EC1, spersinicol, Novartis;
EPC1, prednisynth, Schazoo) were purchased from local
pharmacy shop, Karachi, Pakistan. Methanol and chloro-
form of analytical grade were purchased from the Fisher
Scientific (UK). Deionized water was obtained from
Millipore Milli Q Plus System (Bedford, USA). Sodium
hydroxide was purchased from BioM Laboratories (Cer-
ritos, USA) while hydrochloric acid (HCl) and hydrogen
peroxide (H2O2, 35% v/v) were obtained from Fisher
Scientific (UK).
Instrumentation and chromatographic system
Stress degradation studies were performed using parallel
synthesizer (Smart Start Synthesizer, Chem Speed Ltd.,
Switzerland) with sixteen reaction vessels. Planar chro-
matography was performed by spotting the sample on
TLC glass plate, pre-coated with silica gel 60F-254 (20 ×
10 cm) with the aid of CAMAG microliter sample syr-
inge using CAMAG automatic TLC Linomat V applica-
tor (Muntenz, Switzerland). A constant sample
application rate of 0.1 μL/s was adopted and the dis-
tance between the two bands was 6 mm. 15 mL of
mobile phase (chloroform: methanol, 14:1 v/v) was used
for linear ascending development and chromatogram
was allowed to move to a distance of 8 cm, in twin
trough glass chamber (CAMAG). The chamber satura-
tion time for mobile phase was 8 minutes at 25 ± 2°C
with relative humidity 42 ± 5%. The developed TLC
plate was dried with the help of air dryer for 4 min.
Densitometric scanning was performed on CAMAG
Reprostar scanner III in the reflectance absorbance
mode at multiwavelength (lmax, 243 nm for predniso-
lone acetate and lmax, 278 nm for chloramphenicol) by
utilizing deuterium lamp as the source of radiation.
Quantitative evaluation was performed via peak areas by
WinCats software (version 1.2.3). Densitometric scan-
ning parameters were as follows: bandwidth: 10 mm, slit
width: 0.45 mm, slit length: 5 mm, scanning speed: 10
mm/s.
Preparation of standard solutions and pharmaceutical
samples
Three stock solutions were prepared by dissolving 100
mg of each prednisolone acetate and chloramphenicol in
100 mL methanol, individually and in combination.
Working standard solutions were prepared by dilution
Figure 1 Structures of prednisolone acetate (1) and
chloramphenicol (2).
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of stock solution with methanol to give solutions in con-
centration range of 30-1000 μg/mL for calibration curve.
Six-point calibration curve was formed by spotting 6 μL
of each standard solution in concentration range of 200-
6000 ng/spot containing both components, each concen-
tration was spotted thrice on six replicate plates. For
sample preparation, 1 mL ophthalmic samples (P1, P2,
P3 and P4) containing 10 mg of prednisolone acetate
were diluted in 20 mL volumetric flasks with methanol,
separately. Similarly, 1 mL of spersinicol and chloroptic
containing 0.5% chloramphenicol was diluted in 10 mL
volumetric flasks with methanol. Chloramphenicol cap-
sules, equivalent to 2500 mg (chlormycetin) were placed
in 500 mL of volumetric flask and after addition of 100
mL water, heated on steam bath till the capsules weredi-
sintegrated. After further addition of 300 mL water, it
was again heated on steam bath with mixing. After cool-
ing to room temperature, it was diluted to volume with
water. 5 mL of the resulting solution was transferred to
100 mL volumetric flask and diluted with methanol
[16,17]. 1 mL ophthalmic samples (prednisynth and pre-
dnicol) containing 5 mg of prednisolone acetate and 2
mg chloramphenicol were diluted in 10 mL volumetric
flasks with methanol [4,12]. In similar manner, solutions
for expired spersinicol and prednisynth were also pre-
pared (1 mL in 10 mL volumetric flask). 6 μL of each
sample was applied on TLC plate for chromatographic
analysis.
Method validation
The developed method was validated as per the require-
ments of the ICH guidelines. Linearity was evaluated by
determining six standard working solutions at a concen-
tration 200-6000 ng/spot. Peak area and concentration
was subjected to the least square linear regression equa-
tion to calculate the regression data and correlation
coefficients. In order to calculate S/N ratio for LOD and
LOQ, the formulae used were 3.3 δ/S and 10 δ/S,
respectively where δ is the residual error and S stands
for slope of calibration curve. In order to check the
robustness, following parameters were deliberately chan-
ged within the range of ± 5% at three different concen-
tration levels (200, 400 and 800 ng); amount of mobile
phase, mobile phase composition, time from spotting to
chromatography, time from chromatography to scanning
and chamber saturation time. Intra-day and inter-day
precisions were determined with the standards and
degraded reaction mixtures. For method repeatability,
assay at three different concentration levels (200, 400
and 800 ng) was repeatedly performed six times on the
same day (intra-day). For reproducibility, same samples
at three concentration levels (200, 400 and 800 ng) were
analyzed in different days (inter-day) and results were
statistically evaluated in terms of % R.S.D. For recovery
studies, pre analyzed pharmaceutical drugs containing
prednisolone acetate (P1), chloramphenicol (C1) and
both in combination (PC1) were spiked with extra 25,
50 and 75% of prednisolone acetate and chlorampheni-
col. The specificity of the proposed method was ana-
lyzed by overlapping the densitogram of the standard
and samples and comparing it at peak start, peak apex
and peak end positions.
Preparation of forced degradation products
Methanolic stock solutions (1 mg/mL) of both predniso-
lone acetate (set 1) and chloramphenicol (set 2) were
prepared, separately and in combination (set 3) to per-
form forced degradation studies in parallel synthesizer
by refluxing the reaction mixtures for two hours at 80°
C. After the reactions were completed, all the solutions
were preserved at -80°C till analysis. Average peak areas
of active components were analyzed after triplicate
analysis.
For acidic hydrolysis, 1N and 5N HCl were used, for
alkaline hydrolysis, 0.1N, 1N and 5N NaOH were used
while for neutral hydrolysis Milli Q water was used. 3
mL of each concentration of acidic and alkaline solu-
tions and Milli Q water were added into 3 mL (1 mg/
mL) stock solutions of all three sets. To study wet heat-
ing degradation, 3 mL (1 mg/mL) of stock solution of
each set 1, set 2 and set 3 was subjected to degradation.
Oxidation was carried out by adding 1 mL of H2O2
(35% v/v) in 3 mL stock solution of each set. All the
resultant solutions were refluxed for two hours at 80°C
in parallel synthesizer. 1 μL (500 ng/spot) of 1N HCl,
0.5 μL (250 ng/spot) of 5N HCl, 4 μL (2000 ng/spot) of
0.1N, 1N and 5N NaOH treated solutions, 4 μL (2000
ng/spot) of neutral hydrolysis, 6 μL (6000 ng/spot) from
wet heat degradation mixture and 4 μL (3000 ng/spot)
from oxidation mixture were applied on TLC plate in
triplicate for chromatographic analysis.
Dry heat degradation was conducted by taking stan-
dard prednisolone acetate and chloramphenicol and
heated in oven at 90°C for 4 hrs. 1 mg of each treated
standard was dissolved in 1 mL of methanol and 4 μL
(4000 ng/spot) of resultant solution of each, predniso-
lone acetate, chloramphenicol and both in combination
was applied on TLC plate in triplicate for chromato-
graphic analysis. For oxidation reaction at room tem-
perature, 3 mL stock solution of each set was added
with 1 mL of H2O2 (35% v/v) and the resultant solutions
were kept for 24 hours at room temperature. 4 μL (3000
ng/spot) of each treated solution was applied on TLC
plate in triplicate for chromatographic analysis. In order
to evaluate photochemical degradation of prednisolone
acetate, chloramphenicol and both in combination,
stock solution of each set was directly exposed to the
sunlight for three days from 8 to 18 hrs at 30 ± 2°C. 6
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μL (6000 ng/spot) of each treated solution was applied
on TLC plate in triplicate for chromatographic analysis.
Results and discussion
Optimization of TLC system and method validation
With the aim to develop a reliable stability indicating
method, solvent system was optimized with standards,
samples and degraded products. Different solvent sys-
tems of 2-propanol, toluene, ether, chloroform, metha-
nol, glacial acetic acid and acetone were tried in varying
ratios. Solvent systems and resulting Rf values of both
standards are summarized in Table S1 [see Additional
file 1]. Most of the solvent systems showed diffused
spots of prednisolone acetate. Suitable separation with
best resolution was achieved with chloroform: methanol
(14: 1 v/v) which showed sharp bands with Rf value of
chloramphenicol at 0.21 ± 0.02 and of prednisolone
acetate at 0.41 ± 0.03 (Figure 2).
Standard calibration curve for both prednisolone acetate
and chloramphenicol in the concentration range of 200-
6000 ng was found linear with r2 ± S.D. 0.9966 ± 3.5
and 0.9920 ± 2.5, respectively. For Intra-day and inter-
day precision, % R.S.D. observed for prednisolone acet-
ate was 1.32 and 3.90, respectively while for chloram-
phenicol, 1.09 and 1.68, respectively. For prednisolone
acetate and chloramphenicol, LODs were found to be
4.77 and 3.00 ng/μL, respectively while LOQs were
found to be 14.46 and 9.12 ng/μL, respectively. For
robustness analysis, the S.D. of peak area of standard
levels (200, 400 and 800 ng) was estimated for each
parameter. S.D. was 1.07 and 3.9 for changing the
amount of mobile phase, 2.48 and 2.70 for varying in
mobile phase composition, 0.95 and 2.96 for varying
time from spotting to chromatography, 0.56 and 1.09
for varying time from chromatography to scanning and
1.53 and 1.32 for varying chamber saturation time for
prednisolone acetate and chloramphenicol, respectively.
SD for peak areas were calculated and summarized in
Table S2 [see Additional file 1]. Spiking studies showed
recovery of prednisolone acetate (98-104%) and chlor-
amphenicol (93-101%) from their pharmaceutical pro-
ducts (Table S3 [see Additional file 1]). Peak purity was
estimated by comparing the peak positions of both pre-
dnisolone acetate and chloramphenicol in standard
spectra with those in reaction solutions. Good correla-
tion, r2 (start, middle) = 0.999 and r2 (middle, end) =
0.9999 was observed by comparing the spectra of stan-
dard and samples, in both cases. The linear regression
data and the method validation results are summarized
in Table 1.
Stability indicating property in prednisolone acetate
76.2% of prednisolone acetate was decomposed in 1N HCl
and 100% in 5N HCl. Three additional peaks at Rf 0.01,
Figure 2 Chromatogram of (a) standard chloramphenicol at
lmax 278 nm (b) standard prednisolone acetate at lmax 243
nm (c) standard prednisolone acetate and chloramphenicol in
combination at l 278 nm.
Table 1 Linear regression data and validation parameters
of prednisolone acetate (1) and chloramphenicol (2).
Parameters Prednisolone
acetate
(at lmax 243 nm)
Chloramphenicol
(at lmax 278 nm)
Linearity range 200-6000 ng/spot 200-6000 ng/spot
Correlation coefficient, r2 ±
SD
0.9966 ± 3.5 0.9920 ± 2.5
Slope ± SD 2.42 ± 0.5 2.74 ± 0.34
Intercept ± SD 1106 ± 0.48 4183 ± 2.15
Y = mx + c 2.42x + 1106 2.738x + 4183
Intra-day (n = 3), % RSD 1.32 1.09
Inter-day (n = 3), % RSD 3.90 1.68
Limit of detection 4.77 ng/μL 3.0 ng/μL
Limit of quantification 14.46 ng/μL 9.12 ng/μL
Robustness Robust Robust
Specificity Specific Specific
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0.03, and 0.29 were commonly generated in both acidic
reaction mixtures. In addition to those peaks, three addi-
tional peaks at Rf 0.17, 0.19 and 0.73 were only generated
in 1N HCl reaction mixture while four additional peaks at
Rf 0.02, 0.58, 0.78 and 0.80 were only obtained under
strong acidic condition (5N HCl). Moreover, 100% degra-
dation was observed under alkaline conditions. Degraded
peaks were observed at Rf 0.01, 0.02 and 0.50. In addition
to common peaks, some additional peaks were also
observed. Three peaks were at Rf 0.17, 0.36 and 0.78 in
0.1N NaOH, and peaks at Rf 0.03 and 0.29 in 1N and 5N
NaOH treated solutions, respectively. Prednisolone acetate
showed 77.3% degradation by neutral hydrolysis with four
additional peaks at Rf 0.01, 0.02, 0.17 and 0.29. Predniso-
lone acetate degradations under wet and dry heating were
95.8 and 18.5%, respectively. Both conditions showed com-
mon degraded peaks at Rf 0.01, 0.17, 0.26 and 0.47, while
additional peaks were observed at Rf 0.29, 0.46 and 0.80
for wet heating and Rf 0.78 for dry heating conditions.
Both oxidation mixtures, refluxed for 2 hours at 80°C and
24 hours at room temperature, showed 21.05% and 5.47%
degradation, respectively with three common peaks at Rf
0.05, 0.14, and 0.29. Under photochemical conditions,
100% degradation was observed with the degraded peaks
at Rf 0.01, 0.29, 0.33, 0.47, 0.58, and 0.73.
Prednisolone acetate showed greater degradation sus-
ceptibility to acidic, alkaline and neutral hydrolyses, wet
heating and photochemical conditions. Total eighteen
degraded products were observed under various stress
conditions with some common and different peaks.
Peaks with higher Rf values indicated less polar nature
than prednisolone acetate. A common degraded product
with Rf 0.01 was attributed to all the stress conditions
except oxidation reaction. Degraded product with Rf 0.02
was only generated by acidic (5N HCl), alkaline (0.1, 1
and 5N NaOH) and neutral hydrolysis. Peak at Rf 0.03
was generated under acidic (1 and 5N HCl) and alkaline
(1N NaOH) hydrolysis while peaks at Rf 0.05 and 0.14
were only obtained by oxidation reaction. Degraded pro-
duct at Rf 0.17 was commonly generated by acidic (1N
HCl), alkaline (0.1N NaOH) and neutral hydrolysis and
wet and dry heating degradation, while peak at Rf 0.26
was only found in wet and dry heating conditions. Peak
at Rf 0.29 was found in various stress conditions includ-
ing acidic (1 and 5N HCl), alkaline (1 and 5N NaOH)
and neutral hydrolysis, wet heating, oxidation and photo
degradation. Peaks at Rf 0.33 and 0.36 are the characteris-
tic peaks of photo degradation and alkaline hydrolysis
(0.1 N NaOH), respectively. Similarly peak at Rf 0.46 was
only generated in wet heat degradation reaction, while a
peak with Rf 0.47 was observed in wet and dry heating
and photo degradation conditions. Degraded product at
Rf 0.58 was generated by acidic hydrolysis (5N HCl) and
photo degradation. Peak with Rf 0.73 was found in acidic
hydrolysis (1N HCl) and photo degradation. Degraded
peak at Rf 0.78 was commonly generated by acidic hydro-
lysis (5N HCl), alkaline hydrolysis (0.1N NaOH) and dry
heating. Degraded product at Rf 0.80 was generated
through acidic hydrolysis (5N HCl) and wet heating
degradation. Stress degradation study of prednisolone
acetate is summarized in Table 2. Chromatograms of
stress degraded products obtained from prednisolone
acetate are shown in Figures 3 and 4 while video densito-
gram pictures are shown in Figure 5.
Stability indicating property in chloramphenicol
Chloramphenicol was 23.7% degraded in 1N HCl and
69.3% in 5N HCl. Common degraded peaks were
observed at Rf 0.01 and 0.04, while in strong acidic med-
ium an additional peak generated at Rf 0.81. Under alka-
line conditions, chloramphenicol was 100% degraded
and a common degraded peak at Rf 0.01 was also gener-
ated. Under all alkaline conditions, additional degraded
products were observed at Rf 0.44 and 0.79, while peaks
at Rf 0.81 were found in 1N NaOH treated solution.
Three additional peaks at Rf 0.02, 0.04 and 0.48 were
found in 5N NaOH treated solution. A single degraded
product was found under neutral hydrolysis at Rf 0.01.
In wet and dry heat degradation conditions, two com-
mon additional peaks were found at Rf 0.01 and 0.79.
Under oxidation conditions, three additional peaks at Rf
0.01, 0.12 and 0.31 were generated, while seven






Rf of degraded products
Acidic hydrolysisa
1N HCl 76.26 0.01, 0.03,0.17, 0.19, 0.29, 0.73
5N HCl 100 0.01, 0.02, 0.03, 0.29,
0.58,0.78,0.80
Basic hydrolysisa
0.1N NaOH 100 0.01, 0.02, 0.17, 0.36, 0.50,0.78
1N NaOH 100 0.01, 0.02, 0.03, 0.29, 0.50
5N NaOH 100 0.01, 0.02, 0.29, 0.50
Neutral hydrolysisa
H2O 77.26 0.01, 0.02, 0.17, 0.29
Wet heatinga 95.86 0.01, 0.17, 0.26, 0.29, 0.46, 0.47,
0.80
Dry heating 18.566 0.01, 0.17, 0.26, 0.47, 0.78
Photochemical 100 0.01, 0.29, 0.33, 0.47, 0.58, 0.73
Oxidation
35%v/v H2O2
a 21.05 0.05, 0.14, 0.29
Oxidation at room
temp
5.47 0.05, 0.14, 0.29
aReflux in parallel synthesizer for two hours at 80°C
Musharraf et al. Chemistry Central Journal 2012, 6:7
http://journal.chemistrycentral.com/content/6/1/7
Page 5 of 9
additional peaks at Rf 0.01, 0.09, 0.15, 0.27, 0.44, 0.81
and 0.85 were found by photochemical degradation.
Chloramphenicol showed more degradation to alkaline,
wet heating and photochemical stress conditions.
Degraded product with Rf 0.01 was commonly formed
under all stress conditions while degraded peak with Rf
0.02 was observed only under alkaline hydrolysis (5N
NaOH). Peak with Rf 0.04 was generated by acidic (1 and
5N HCl) and alkaline hydrolysis (1 and 5N NaOH), while
peak at Rf 0.48 was observed only in alkaline hydrolysis
(5N NaOH). Degraded products with Rf 0.12 and 0.15
were found under oxidation and photo degradation con-
ditions, respectively, while peak with Rf 0.31 was formed
only in oxidation reaction. Peak with Rf 0.44 was gener-
ated by alkaline hydrolysis (0.1N NaOH) and photo
degradation reactions. Degraded peak with Rf 0.79 was
generated by alkaline hydrolysis (0.1N NaOH) and wet
and dry heat degradations. Degraded product with Rf
0.81 was generated by acidic hydrolysis (5N HCl), alka-
line hydrolysis (1N NaOH) and photo degradation
conditions. Similarly peaks with Rf 0.09, 0.27 and 0.85
were only generated through photo degradation reaction.
Stress degradation study of chloramphenicol is summar-
ized in Table 3. Chromatograms of chloramphenicol
stress degraded products are shown in Figures 3 and 4
while video densitogram pictures are shown in Figure 5.
Stability indicating property of prednisolone acetate and
chloramphenicol in combination
In comparison with the individual standard solutions, a
combined standards solution showed two additional
peaks under acidic (1N HCl) condition at Rf 0.78 and
0.81 while three degraded products of prednisolone
acetate at Rf 0.03, 0.19 and 0.73 were missing. 5N HCl
stress condition showed two additional peaks at Rf 0.17
and 0.38. Peak at Rf 0.81 corresponding to the degraded
product of chloramphenicol while degraded products of
prednisolone acetate with Rf 0.03 and 0.80 were missing.
Moreover, under both acidic conditions, prednisolone
acetate was 100% degraded.
Under alkaline conditions, chloramphenicol and pre-
dnisolone acetate were completely degraded. Two com-
mon additional peaks were generated under all alkaline
conditions at Rf 0.01 and 0.02. Under 0.1N NaOH stress
Figure 3 Chromatogram of prednisolone acetate at lmax 243
nm (1), chloramphenicol at lmax 278 nm (2) and prednisolone
acetate and chloramphenicol at l 278 nm in combination (3)
subjected to (a) acidic hydrolysis (1N HCl) (b) alkaline
hydrolysis (0.1N NaOH) (c) neutral hydrolysis.
Figure 4 Chromatogram of prednisolone acetate at lmax 243
nm (1), chloramphenicol at lmax 278 nm (2) and prednisolone
acetate and chloramphenicol at l 278 nm in combination (3)
subjected to (a) wet heat (b) photodegradation (c) oxidation at
room temperature.
Figure 5 TLC desitometric pictures of degradation products of
chloramphenicol (1), prednisolone acetate (2), chloramphenicol
and prednisolone acetate in combination (3). (a) under 1N HCl
(4, 5, 6), 5N HCl (7, 8, 9), 0.1N NaOH (10, 11, 12), 1N NaOH (13, 14,
15), 5N NaOH (16, 17, 18), (b) under neutral hydrolysis (4, 5, 6), wet
heating (7, 8, 9), dry heating (10, 11, 12), photo degradation (13, 14,
15) and oxidation at room temperature (16, 17, 18).
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condition, two additional peaks were found at Rf 0.29
and 0.85 while chloramphenicol degraded peak at Rf
0.44 and prednisolone acetate degraded peaks at Rf 0.36
and 0.78 were missing. Moreover, under 1N NaOH
stress condition, an additional peak was observed at Rf
0.44 while chloramphenicol degraded products at Rf
0.04 and 0.81 and prednisolone acetate degraded pro-
duct at Rf 0.50 were missing. In 5N NaOH treated
solution, comparison showed an additional peak at Rf
0.31 while chloramphenicol degraded products at Rf
0.04 and 0.48 and prednisolone acetate degraded pro-
ducts at Rf 0.29 and 0.50 were missing. In neutral
hydrolysis reaction mixture, an additional peak was gen-
erated at Rf 0.79, while peak for prednisolone acetate at
Rf 0.02 was missing.
Similarly an additional degraded product at 0.50 was
observed in combined sample under wet heat degrada-
tion while degraded products of prednisolone acetate at
Rf 0.47 and 0.80 were missing. Under dry heat degrada-
tion condition, comparison showed an additional peak
at Rf 0.73 while prednisolone acetate degraded peaks at
Rf 0.17 and 0.78 were missing. Under wet heat degrada-
tion condition, prednisolone acetate was 17% degraded
while chloramphenicol was degraded up to 36.9%.
For oxidation reaction, two conditions were applied,
under oxidation condition 1 (refluxed for two hours at
80°C), additional peak at Rf 0.55 while two additional
peaks at Rf 0.23 and 0.55 were observed under oxidation
condition 2 (reaction mixture kept for 24 hours at room
temperature). Prednisolone acetate degraded peaks at Rf
0.05, 0.14 and 0.29 were missing.
Under photochemical degradation condition, addi-
tional degraded products at Rf 0.49, 0.50 and 0.69 were
generated only in combined sample while degraded pro-
ducts of prednisolone acetate at Rf 0.29 and 0.33 and
those of chloramphenicol at Rf 0.09, 0.15, 0.28, 0.44,
0.81 and 0.85 were missing. Stress degradation study of
prednisolone acetate and chloramphenicol in combined
sample is summarized in Table 4 while video densito-
gram pictures are shown in Figures 3 and 4.






Rf of degraded products
Acidic hydrolysisa
1N HCl 23.75 0.01, 0.04
5N HCl 69.36 0.01, 0.04, 0.81
Basic hydrolysisa
0.1N NaOH 100 0.01, 0.44, 0.79
1N NaOH 100 0.01, 0.04, 0.81
5N NaOH 100 0.01, 0.02, 0.04, 0.48
Neutral hydrolysisa
H2O 14.35 0.01
Wet heatinga 28.44 0.01, 0.79





a 4.129 0.01, 0.12, 0.31
Oxidation at room
temp
9.58 0.01, 0.12, 0.31
aReflux in parallel synthesizer for two hours at 80°C
Table 4 Summary of stress degradation studies of prednisolone acetate and chloramphenicol in combination
Degradation conditions % Degradation of 1 % Degradation of 2 Rf of degraded products
Acidic hydrolysisa
1N HCl 100 31.8 0.01, 0.04, 0.17, 0.29,0.78,
0.81
5N HCl 100 82.7 0.01, 0.02, 0.04, 0.17, 0.29,
0.38,0.58, 0.78
Basic hydrolysisa
0.1 N NaOH 100 100 0.01, 0.02, 0.17,0.29, 0.50, 0.79,0.85
1N NaOH 100 100 0.01, 0.02, 0.03, 0.29,0.44
5N NaOH 100 100 0.01, 0.02, 0.31
Neutral hydrolysisa
H2O 74.52 17.9 0.01, 0.17, 0.29, 0.79
Wet heatinga 17 36.9 0.01, 0.17, 0.29, 0.50,0.79
Dry heating 0 0 0.01, 0.26, 0.47,0.73,0.79
Photochemical 85.808 17.1 0.01, 0.47, 0.49,0.50,0.58, 0.69,0.73
Oxidation
35%v/v H2O2
a 30.56 7.20 0.01, 0.12, 0.31, 0.55
At room temp 9.029 13.4 0.01, 0.12, 0.23,0.31, 0.55
aReflux in parallel synthesizer for two hours at 80°C
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Analysis of marketed samples
In prednisolone acetate eye drops, prednisolone acetate
was found 97% (P1), 100% (P2), 93% (P3), 93% (P4) and
81% (P5) of the label claim. In chloramphenicol eye
drops and capsule, the %s of chloramphenicol were
found 98 (C1), 95 (C2) and 99 (C3). In eye drops, con-
taining prednisolone acetate and chloramphenicol in
combination, the %s of chloramphenicol were 96 (PC1)
and 95 (PC2) while prednisolone acetate was found
100% in both samples. Two expired pharmaceutical pro-
ducts were also analyzed. In a expired sample (spersini-
col), peak was not found for chloramphenicol at Rf 0.21
(100% degradation) but six degraded peaks were found
at Rf 0.01, 0.09, 0.19, 0.15, 0.38 and 0.58. Stress degrada-
tion study data showed that peak with Rf 0.01 was com-
monly formed under all stress conditions. Degraded
products with Rf 0.09 and 0.15 were formed by photo-
degrdation Degraded products with Rf 0.38 and 0.58
were not found under any stress condition applied to
chloramphenicol alone. Degraded product with Rf 0.38
was generated in combined sample of prednisolone acet-
ate and chloramphenicol under acidic hydrolysis (5N
HCl). In expired prednisynth product (light yellow in
color), peak for chloramphenicol was found but with
59% degradation and prednisolone acetate was degraded
up to 72.2%. Five additional peaks were also found at Rf
0.01, 0.15, 0.26, 0.38 and 0.58 (Figure 6). Comparison
showed that degraded product at Rf 0.01 was a common
product in both, individual and in combination.
Degraded products at Rf 0.15 and 0.38 were generated
by the degradation of chloramphenicol. Degraded pro-
ducts with Rf 0.26 (found under dry and wet heat degra-
dation conditions) and 0.58 (produced under acidic
hydrolysis and photo degradation) were associated with
the degradation of prednisolone acetate (Table 5).
Conclusions
A validated TLC method for routine analysis to deter-
mine the stability of prednisolone acetate and chloram-
phenicol in pharmaceutical dosage forms has been
developed. Current study demonstrates the degradation
susceptibility of drugs to different stress conditions and
thus helps in determining the changes in chemical, phy-
sical and microbiological properties of the drug samples
with time. It also helps in understanding the mechanism
and pathway of degraded products formation and in
developing a profile reflecting the changes in identity,
purity and potency of the product. The comparison of
stress degradation in individual and combined formula-
tions reveals the effect on % degradation and the num-
ber of degraded products. The developed stability
indicating TLC method is simple, reproducible and can
be used for the simultaneous analysis of two active com-
ponents (chloramphenicol and prednisolone acetate). It
appears suitable for routine analysis of these compo-
nents selectively in presence of their degraded products
in individual and in combined pharmaceutical
formulations.
Figure 6 Chromatogram of (a) expired spersinicol and (b)
expired prednisynth at 278 nm.
Table 5 Analysis of pharmaceutical products.









P1 2909.94 3.002 - -
P2 3000 0 - -
P3 2778.6 7.38 - -
P4 2803.05 6.565 - -
P5 2440.5 18.65 - -
C1 - - 2956.5 1.45
C2 - - 2850.9 4.97
C3 - - 2984.4 0.52
PC1 3000 0 1158.72 3.44
PC2 3000 0 1144.44 4.63
EC1 - - 0 100
EPC1 833.55 72.215 490.05 59.15
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Additional material
Additional file 1: Supplementary Material. Additional file contains the
supplementary data regarding recovery studies, robustness and solvent
optimization.
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